These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


435 related items for PubMed ID: 18285494

  • 1. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
    Park YS, Lee JH, Hung CF, Wu TC, Kim TW.
    Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A, Kumar M, Nagar DP, Pal V, Goel AK.
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors.
    Wang HC, An HJ, Yu YZ, Xu Q.
    Immunol Lett; 2015 Feb; 163(2):206-13. PubMed ID: 25102364
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination.
    Hahn UK, Alex M, Czerny CP, Böhm R, Beyer W.
    Int J Med Microbiol; 2004 Jul; 294(1):35-44. PubMed ID: 15293452
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralization.
    Dumas EK, Nguyen ML, Cox PM, Rodgers H, Peterson JL, James JA, Farris AD.
    Vaccine; 2013 Apr 03; 31(14):1856-63. PubMed ID: 23415781
    [Abstract] [Full Text] [Related]

  • 14. CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.
    Devera TS, Aye LM, Lang GA, Joshi SK, Ballard JD, Lang ML.
    Infect Immun; 2010 Apr 03; 78(4):1610-7. PubMed ID: 20123711
    [Abstract] [Full Text] [Related]

  • 15. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.
    Infect Immun; 2007 Apr 03; 75(4):1827-34. PubMed ID: 17145938
    [Abstract] [Full Text] [Related]

  • 16. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.
    Wui SR, Kim HK, Han JE, Kim JM, Kim YH, Chun JH, Cho YJ, Lee NG.
    Int Immunopharmacol; 2011 Sep 03; 11(9):1195-204. PubMed ID: 21492746
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the human immune response to the UK anthrax vaccine.
    Baillie L, Townend T, Walker N, Eriksson U, Williamson D.
    FEMS Immunol Med Microbiol; 2004 Oct 01; 42(2):267-70. PubMed ID: 15364114
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S, Little S, Friedlander A, Fritz D, Fellows P.
    Microbiology (Reading); 2001 Jun 01; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.